Equity - Schedule of Common Stock Purchase Warrants Issued and Outstanding (Details) - $ / shares |
3 Months Ended | 12 Months Ended |
---|---|---|
Mar. 31, 2020 |
Dec. 31, 2019 |
|
Stockholders' Equity Note [Abstract] | ||
Warrants Outstanding, Beginning balance | 57,043,836 | 51,066,864 |
Warrants Outstanding, Granted | 8,400,000 | 12,250,000 |
Warrants Outstanding, Exercised | (1,650,000) | (125,000) |
Warrants Outstanding, Expired | (2,005,000) | (6,148,028) |
Warrants Outstanding, Ending balance | 61,788,836 | 57,043,836 |
Weighted Average Exercise Price, Beginning balance | $ 0.14 | $ 0.20 |
Weighted Average Exercise Price, Granted | 0.16 | 0.15 |
Weighted Average Exercise Price, Exercised | 0.08 | 0.09 |
Weighted Average Exercise Price, Expired | 0.23 | 0.25 |
Weighted Average Exercise Price, Ending balance | $ 0.16 | $ 0.14 |
X | ||||||||||
- Definition Weighted Average Exercise Price, Expired. No definition available.
|
X | ||||||||||
- Definition Warrants Weighted Average Exercise Price. No definition available.
|
X | ||||||||||
- Definition Weighted Average Exercise Price, Exercised. No definition available.
|
X | ||||||||||
- Definition Weighted Average Exercise Price, Granted. No definition available.
|
X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- References No definition available.
|